Hu J, Wang S Z, Forray C, el-Fakahany E E
Division of Neuroscience Research in Psychiatry, University of Minnesota Medical School, Minneapolis 55455.
Mol Pharmacol. 1992 Aug;42(2):311-21.
A large number of diverse pharmacological agents bind to a secondary domain on the muscarinic receptor, to influence allosterically the interaction of ligands at the primary binding site. Based on common structural features of these antagonists, we examined the interaction of protamine, an endogenous polycationic peptide, and of polyamines with muscarinic receptors in rat heart. Our results provide several lines of qualitative evidence that protamine allosterically modulates the conformation of muscarinic receptors, in a marked negatively cooperative manner. It decelerated the dissociation of N-[3H]methylscopolamine ([3H] NMS) initiated by atropine, in a concentration-dependent fashion. Inhibition by protamine of [3H]NMS binding at equilibrium showed a distinct plateau, which increased in magnitude at higher ligand concentrations. Scatchard analysis of saturation isotherms of [3H]NMS binding in the absence and presence of protamine indicated that protamine did not alter Bmax in a statistically significant fashion, although there was a trend of a concentration-dependent increase in this parameter. On the other hand, it caused a marked concentration-dependent decrease in the affinity of [3H]NMS, and this effect reached a ceiling limit. However, there were marked quantitative deviations of the interaction of protamine from a simple ternary allosteric model. Some of these discrepancies could be explained by the tendency of protamine to increase Bmax. The allosteric actions of protamine demonstrated in kinetic and equilibrium experiments were selective for m1 and m2 muscarinic receptors, compared with m3, m4, and m5 receptors, as studied in Chinese hamster ovary cells transfected with the genes of the different muscarinic receptors. Arginine residues play an important role in the allosteric interaction of protamine, inasmuch as poly-L-arginine qualitatively mimicked the effects of protamine. In contrast, no effects of the polyamines spermine, spermidine, and putrescine were observed on [3H]NMS binding. This is the first report on the allosteric modulation of muscarinic receptors by an endogenous peptide.
大量不同的药理剂与毒蕈碱受体上的一个二级结构域结合,以变构方式影响配体在主要结合位点的相互作用。基于这些拮抗剂的共同结构特征,我们研究了内源性聚阳离子肽鱼精蛋白以及多胺与大鼠心脏毒蕈碱受体的相互作用。我们的结果提供了几条定性证据,表明鱼精蛋白以显著的负协同方式变构调节毒蕈碱受体的构象。它以浓度依赖的方式减缓了由阿托品引发的N-[3H]甲基东莨菪碱([3H]NMS)的解离。鱼精蛋白对平衡时[3H]NMS结合的抑制呈现出明显的平台期,在较高配体浓度下其幅度增加。对在有无鱼精蛋白存在情况下[3H]NMS结合饱和等温线的Scatchard分析表明,尽管该参数有浓度依赖性增加的趋势,但鱼精蛋白并未以统计学上显著的方式改变Bmax。另一方面,它导致[3H]NMS的亲和力出现明显的浓度依赖性降低,且这种效应达到了上限。然而,鱼精蛋白的相互作用与简单的三元变构模型存在明显的定量偏差。其中一些差异可以通过鱼精蛋白增加Bmax的趋势来解释。如在转染了不同毒蕈碱受体基因的中国仓鼠卵巢细胞中所研究的那样,与m3、m4和m5受体相比,在动力学和平衡实验中证明的鱼精蛋白的变构作用对m1和m2毒蕈碱受体具有选择性。精氨酸残基在鱼精蛋白的变构相互作用中起重要作用,因为聚-L-精氨酸在质量上模拟了鱼精蛋白的作用。相比之下,未观察到多胺精胺、亚精胺和腐胺对[3H]NMS结合有影响。这是关于内源性肽对毒蕈碱受体变构调节的首次报道。